Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Women With Diagnosed HSDD Women experiencing persistent low sexual desire causing emotional distress may be candidates for FDA-approved bremelanotide therapy
Supporting healthy nervous, respiratory, and gastrointestinal systems*
Ned Tijdschr Geneeskd (2020) 164:D4166
Key takeaways: PT-141 is the standout for libido restoration, working through brain pathways to restore desire rather than just physical arousal
321(Pt 1)207210
US$ 27.03
US$ 24.05
US$ 28.69
